Chain Drug Review - Boehringer to buy Zantac
October 23, 2006 -- RIDGEFIELD, Conn. -- Boehringer Ingelheim Pharmaceuticals Inc. is buying the Zantac brand from Johnson & Johnson for $505.5 million. Sale of...
Drug Store News - Zantac debuts new cool mint tablets
September 10, 2007 -- With its 2006 acquisition of Zantac over-the-counter products in the United States, the Boehringer Ingelheim Consumer Health Care Products Division...
CPA Journal, The - GlaxoSmithKline and the IRS Finally Find Relief with Zantac
June 1, 2008 -- Longstanding Dispute over Transfer Pricing Settled When it comes to transfer pricing, even the most seasoned tax professionals can find themselves...
Internal Medicine News - New OTC Zantac dose
January 1, 2005 -- Zantac is approved in a 150-mcg over-the-counter dose for the relief of heartburn associated with acid indigestion and sour stomach, and for the...
Australasian Business Intelligence - Zantac hits the spot.
September 2, 2003 -- Sep 02, 2003 (B&T - ABIX via COMTEX) An advertising campaign for the Zantac indigestion product has worked well in Australia. The agency...
Business Wire - Pfizer Statement on Zantac 75
June 21, 2003 -- Business Editors/Health/Medical Writers MORRIS PLAINS, N.J.--(BUSINESS WIRE)--June 21, 2003 Pfizer responded to the approval of Prilosec for OTC...
Drug Store News - The FDA has approved ranitidine syrup oral solution USP from Actavis and Taro, the generic equivalent of GlaxoSmithKline's Zantac syrup
April 23, 2007 -- The FDA has approved ranitidine syrup oral solution USP from Actavis Taro, the generic equivalent of GlaxoSmithKline's Zantac syrup. Ranitidine syrup...
Advertising Age - Cramer-Krasselt wins $32M Zantac business; Chicago shop bests JWT, TBWA in review for heartburn blockbuster.(News)(Boehringer Ingelheim)(Brief article)
March 26, 2007 -- Byline: JEREMY MULLMAN jmullman@adage.com Cramer-Krasselt now has a prescription-drug account ideal for curing its CareerBuilder-related...
Grocer - Blue Man is back
June 7, 2008 -- GlaxoSmithKline's heartburn and indigestion brand Zantac returns to the small screen next week with its Blue Man commercial in a 615,000 [pounds...
Chain Drug Review - Dynamics of Rx to O-T-C switches
June 30, 2008 -- Over the last 25 years the health care arena has been abuzz about the potential of Rx to O-T-C switches to become one of the key spokes in the wheel...
